The authors of a paper in the Journal of Biological Chemistry (JBC) have retracted it, but don’t ask us why.
This being the JBC, the retraction notice for “Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-κB Pathway” is the very definition of opaque: Continue reading Mysterious retraction in the Journal of Biological Chemistry for Takashi Tsuji’s group
Three papers in Current Eye Research have apparently not quite lived up to the journal’s name. The journal in November retracted three studies from a group of authors in China who had previously published the papers in their native language.
Here’s the notice, which also appears in this month’s print edition: Continue reading Seeing double: Current Eye Research retracts three papers for duplication
Earlier this year we reported on the case of Bernardino Saccomanni, an apparently shameless plagiarist with a fondness for publishing in the orthopedics literature.
Somehow, we’re not surprised to learn that Saccomanni may not have been totally above board in other ways, too.
According to Robert Lindsay, editor of Osteoporosis International, whose journal has retracted one of Saccomanni’s plagiarized manuscripts, the researcher’s stated affiliation on several recent papers — Gabriele D’ Annunzio University Chieti — had long ago severed ties with him: Continue reading Orthopedics plagiarist may have lied about affiliation
Today, without us having planned it, has become the day of retracted papers that found a new home.
This morning, we posted an item about a chimp “culture” paper that was retracted from Biology Letters after its authors found some errors, and then published, with corrections, in the Journal of Human Evolution. This afternoon, we bring you the news of a PLoS ONE paper on longevity genes that is the corrected version of a Science paper retracted last year: Continue reading Sebastiani and Perls longevity genes work finds a new home in PLoS ONE following Science retraction
The authors of a 2011 paper claiming that chimp “culture” has more to do with local habitats than with where the chimps live have retracted it after finding mistakes in their work.
Here’s the notice for the paper, “Variation in chimpanzee ‘culture’ is predicted by local ecology, not geography:” Continue reading Chimp ‘culture’ paper retracted after authors spot errors, now has home at another journal
In two unrelated cases, the Office of Research Integrity (ORI) has sanctioned a grad student and a pair of colleagues, one of whom plagiarized and the other allowed the intellectual theft to go unchecked.
We think the handling of these cases — both first noted briefly by The Chronicle of Higher Education — is worth noting.
Continue reading ORI roundup: Former SUNY grad student, two Kansas U researchers hit with sanctions
Last week, we brought you the tale of a paper about camels that was rejected on submission, but published accidentally, and then retracted. It turns out this was not a unique occurrence.
An eagle-eyed Retraction Watch reader emailed us about another such paper, this one in the Journal of Nanoparticle Research. The study, “Growth of gold flowers on polyacrylonitrile fibers,” appears to have been published online on December 3, 2008. It now sports this retraction notice: Continue reading Another paper rejected, mistakenly published, then retracted, this one in nanotechnology journal
In the wake of the massive allegations of fraud by resveratrol researcher Dipak Das, other researchers in the field are clearly trying to distance themselves from the University of Connecticut scientist. Nir Barzilai told us yesterday, for example, that despite Das seemingly’ impressive publication record, “Rome was not built on Dr. Das.”
Harvard’s David Sinclair went further, telling The New York Times that he didn’t know who Das was: Continue reading So how peripheral was Dipak Das’ resveratrol work, really?
Many Retraction Watch readers will now be familiar with the case of Dipak Das, the resveratrol researcher about whom the University of Connecticut issued a voluminous report yesterday — summary here — detailing 145 counts of data fabrication and falsification. This has been a fast-moving story, so we wanted to highlight a number of updates to our original post, and offer a few more.
First, we have confirmed with publisher Mary Ann Liebert this morning that Das has been relieved of his duties as co-editor in chief of Antioxidants & Redox Signaling. He had shared that post with Chandan Sen, and his name as been removed from the masthead of that journal. Here’s a statement from the publisher: Continue reading Resveratrol fraud case update: Dipak Das loses editor’s chair, lawyer issues statement refuting all charges
The University of Connecticut, in what clearly seems like an attempt to get ahead of damaging news, has announced an “extensive” investigation into research misconduct involving one of its scientists, Dipak K. Das.
According to a press release, the university has notified 11 journals that published Das’ work about the alleged fraud. One area of interest for Das, a government-funded professor of surgery and director of the Cardiovascular Research Center, has been resveratrol, a substance in red wine that has allegedly been linked to improved cardiac health.
The university touted some of his early efforts in this field.
[Please also see our update posted Thursday.]
Here’s what the release has to say: Continue reading UConn resveratrol researcher Dipak Das fingered in sweeping misconduct case
